Pharmaceutical formulation containing a biguanide and an angiotensin antagonist
US7588779B2 · kind B2 · utility
2Cited by
7References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 27, 2005 |
| Grant date | Sep 15, 2009 |
| Priority date | — |
| Expiry date | May 27, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4184
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a angiotensin antagonist is herein disclosed and described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.